Multiple sclerosis and Vitreous opacities
Summary:
Vitreous opacities is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.
The study analyzes which people have Vitreous opacities with Multiple sclerosis. It is created by eHealthMe based on reports of 13 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,084 drugs and 1,365 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
What is Vitreous opacities?
Vitreous opacities (vitreous opacities generally develop as aging changes within the eye) is found to be associated with 60 drugs and 152 conditions by eHealthMe. Check the latest studies of Vitreous opacities.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13 people who have Multiple Sclerosis and Vitreous Opacities are studied.

Gender of people who have Multiple Sclerosis and experienced Vitreous Opacities *:
- female: 84.62 %
- male: 15.38 %
Age of people who have Multiple Sclerosis and experienced Vitreous Opacities *:
- 0-1: 0.0 %
- 2-9: 9.09 %
- 10-19: 9.09 %
- 20-29: 0.0 %
- 30-39: 18.18 %
- 40-49: 0.0 %
- 50-59: 54.55 %
- 60+: 9.09 %
Common co-existing conditions for these people *:
- Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 30.77%
- Bipolar Disorder (mood disorder): 4 people, 30.77%
- Pain: 3 people, 23.08%
- Uveitis (inflammation of the uvea): 2 people, 15.38%
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.69%
- Vision Blurred: 1 person, 7.69%
- Stress And Anxiety: 1 person, 7.69%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.69%
- Muscle Tightness: 1 person, 7.69%
- Hypoaesthesia (reduced sense of touch or sensation): 1 person, 7.69%
Common drugs taken by these people *:
- Gilenya: 5 people, 38.46%
- Mavenclad: 4 people, 30.77%
- Ibuprofen: 2 people, 15.38%
- Tysabri: 2 people, 15.38%
- Paracetamol: 2 people, 15.38%
- Diazepam: 1 person, 7.69%
- Latanoprost: 1 person, 7.69%
- Hydrocortisone: 1 person, 7.69%
- Ganciclovir: 1 person, 7.69%
- Gabapentin: 1 person, 7.69%
Common symptoms for these people *:
- Stress And Anxiety: 5 people, 38.46%
- Headache (pain in head): 5 people, 38.46%
- Weight Increased: 4 people, 30.77%
- Bronchial Hyperreactivity: 4 people, 30.77%
- Feeling Cold: 4 people, 30.77%
- Hyperkinetic Heart Syndrome (hyperkinetic heart disease is when the heart is beating faster that it should be): 4 people, 30.77%
- Listless (lack of interest, energy, or spirit): 4 people, 30.77%
- Nasopharyngitis (inflammation of the nasopharynx): 4 people, 30.77%
- Panic Disorder: 4 people, 30.77%
- Lymphocyte Count Decreased: 4 people, 30.77%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Vitreous opacities?
- Check whether Vitreous opacities is associated with a drug or a conditionRelated publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Multiple sclerosis (799,637 reports)
- Vitreous opacities (1,046 reports)
All the drugs that are associated with Vitreous opacities:
- Vitreous opacities (60 drugs)
All the conditions that are associated with Vitreous opacities:
- Vitreous opacities (152 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Vitreous opacities and Multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ileitis Aggravated and Eye Haemorrhage - 4 seconds ago
- Could Keppra cause Lyme Disease? - 5 seconds ago
- Could Nexium cause Neurotoxicity? - 6 seconds ago
- Could Nexium cause Dermatitis Acneiform? - 8 seconds ago
- Hyperthyroidism Aggravated and Red Blood Cell Sedimentation Rate Increased - 11 seconds ago
- Hyperlipidaemia and Oedema Peripheral - 13 seconds ago
- Zopiclone and Suicidal Ideation for Women aged 30-39 - 16 seconds ago
- Zopiclone and Suicidal Thoughts for Women aged 30-39 - 17 seconds ago
- Could Fentanyl Citrate cause Incoherent? - 17 seconds ago
- Could Neurontin cause Actinic Keratosis? - 20 seconds ago